Reprogramming: identifying the mechanisms that safeguard cell identity
暂无分享,去创建一个
[1] H. Snoeck. Calcium regulation of stem cells , 2020, EMBO reports.
[2] Sexually Mature , 2020, Definitions.
[3] R. Sridharan,et al. Coordinated removal of repressive epigenetic modifications during induced reversal of cell identity , 2019, The EMBO journal.
[4] J. Brumbaugh,et al. Inducible histone K-to-M mutations are dynamic tools to probe the physiological role of site-specific histone methylation in vitro and in vivo , 2019, Nature Cell Biology.
[5] L. Morey,et al. Emerging Roles for Polycomb-Group Proteins in Stem Cells and Cancer. , 2019, Trends in biochemical sciences.
[6] Xudong Fu,et al. Myc and Dnmt1 impede the pluripotent to totipotent state transition in embryonic stem cells , 2019, Nature Cell Biology.
[7] S. Orkin,et al. Extensive Recovery of Embryonic Enhancer and Gene Memory Stored in Hypomethylated Enhancer DNA. , 2019, Molecular cell.
[8] R. Jaenisch,et al. Hominoid-Specific Transposable Elements and KZFPs Facilitate Human Embryonic Genome Activation and Control Transcription in Naive Human ESCs , 2019, Cell stem cell.
[9] E. Wagner,et al. Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation. , 2019, The Journal of clinical investigation.
[10] Yi Zhang,et al. Loss of DUX causes minor defects in zygotic genome activation and is compatible with mouse development , 2019, Nature Genetics.
[11] Liang Ming,et al. The role of m6A RNA methylation in cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[12] K. Zaret,et al. Role of H3K9me3 heterochromatin in cell identity establishment and maintenance. , 2019, Current opinion in genetics & development.
[13] Q. Lan,et al. The Critical Role of RNA m6A Methylation in Cancer. , 2019, Cancer research.
[14] J. Hanna,et al. Stage-specific requirement for Mettl3-dependent m6A mRNA methylation during haematopoietic stem cell differentiation , 2019, Nature Cell Biology.
[15] Qiang Wu,et al. Depletion of H3K79 methyltransferase Dot1L promotes cell invasion and cancer stem-like cell property in ovarian cancer. , 2019, American journal of translational research.
[16] Zhike Lu,et al. Histone H3 trimethylation at lysine 36 guides m6A RNA modification co-transcriptionally , 2019, Nature.
[17] Jason D. Buenrostro,et al. Deterministic Somatic Cell Reprogramming Involves Continuous Transcriptional Changes Governed by Myc and Epigenetic-Driven Modules. , 2019, Cell stem cell.
[18] A. Dejean,et al. SUMO Safeguards Somatic and Pluripotent Cell Identities by Enforcing Distinct Chromatin States. , 2018, Cell stem cell.
[19] S. Heath,et al. Transcription Factors Drive Tet2-Mediated Enhancer Demethylation to Reprogram Cell Fate. , 2018, Cell stem cell.
[20] A. Shilatifard,et al. A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis. , 2018, Cancer cell.
[21] F. Supek,et al. Loss of G9a preserves mutation patterns but increases chromatin accessibility, genomic instability and aggressiveness in skin tumours , 2018, Nature Cell Biology.
[22] B. Aronow,et al. H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression , 2018, Nature Communications.
[23] L. Tsang,et al. R-spodin2 enhances canonical Wnt signaling to maintain the stemness of glioblastoma cells , 2018, Cancer Cell International.
[24] R. Sridharan,et al. The role of α-ketoglutarate–dependent proteins in pluripotency acquisition and maintenance , 2018, The Journal of Biological Chemistry.
[25] Jason D. Buenrostro,et al. Neutralizing Gatad2a-Chd4-Mbd3/NuRD Complex Facilitates Deterministic Induction of Naive Pluripotency. , 2018, Cell stem cell.
[26] S. Lacadie,et al. FACT Sets a Barrier for Cell Fate Reprogramming in Caenorhabditis elegans and Human Cells , 2018, Developmental cell.
[27] T. Swigut,et al. Systematic perturbation of retroviral LTRs reveals widespread long-range effects on human gene regulation , 2018, eLife.
[28] Xiaohua Shen,et al. A LINE1-Nucleolin Partnership Regulates Early Development and ESC Identity , 2018, Cell.
[29] O. Klein,et al. Parasitic helminthes induce fetal-like reversion in the intestinal stem cell niche , 2018, Nature.
[30] O. Klein,et al. Parasitic helminthes induce fetal-like reversion in the intestinal stem cell niche , 2018, Nature.
[31] J. Polo,et al. SRSF3 promotes pluripotency through Nanog mRNA export and coordination of the pluripotency gene expression program , 2018, eLife.
[32] F. Sotgia,et al. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication , 2018, The Biochemical journal.
[33] G. Pfeifer. Defining Driver DNA Methylation Changes in Human Cancer , 2018, International journal of molecular sciences.
[34] K. Somasundaram,et al. Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance , 2018, Oncogene.
[35] Katie J. Clowers,et al. Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling , 2018, Cell.
[36] Xiaohui S. Xie,et al. Molecular Mechanisms for CFIm-Mediated Regulation of mRNA Alternative Polyadenylation. , 2018, Molecular cell.
[37] B. Garcia,et al. Genomic and Proteomic Resolution of Heterochromatin and Its Restriction of Alternate Fate Genes. , 2017, Molecular cell.
[38] Juan M. Vaquerizas,et al. A molecular roadmap for the emergence of early-embryonic-like cells in culture , 2017, Nature Genetics.
[39] C. Mayr. Regulation by 3'-Untranslated Regions. , 2017, Annual review of genetics.
[40] Jennifer E. Phillips-Cremins,et al. Crossed wires: 3D genome misfolding in human disease , 2017, The Journal of cell biology.
[41] Stefan Mundlos,et al. The three-dimensional genome: regulating gene expression during pluripotency and development , 2017, Development.
[42] K. Hochedlinger,et al. Emerging roles of the histone chaperone CAF-1 in cellular plasticity. , 2017, Current opinion in genetics & development.
[43] H. Bourbon,et al. Genome Regulation by Polycomb and Trithorax: 70 Years and Counting , 2017, Cell.
[44] Wei Zhao,et al. USP26 functions as a negative regulator of cellular reprogramming by stabilising PRC1 complex components , 2017, Nature Communications.
[45] G. Laible,et al. KDM4B-mediated reduction of H3K9me3 and H3K36me3 levels improves somatic cell reprogramming into pluripotency , 2017, Scientific Reports.
[46] Yuval Kluger,et al. m6A mRNA methylation controls T cell homeostasis by targeting IL-7/STAT5/SOCS pathway , 2017, Nature.
[47] Olivier Elemento,et al. Stem Cell Lineage Infidelity Drives Wound Repair and Cancer , 2017, Cell.
[48] S. Tapscott,et al. Conserved roles for murine DUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons , 2017, Nature Genetics.
[49] Javier Quilez,et al. Transcription factors orchestrate dynamic interplay between genome topology and gene regulation during cell reprogramming , 2017, Nature Genetics.
[50] C. Pilarsky,et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer , 2017, Nature Cell Biology.
[51] Chuan He,et al. m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. , 2017, Cancer cell.
[52] Chunhui Hou,et al. RNA Helicase DDX5 Inhibits Reprogramming to Pluripotency by miRNA-Based Repression of RYBP and its PRC1-Dependent and -Independent Functions. , 2017, Cell stem cell.
[53] Zhike Lu,et al. m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells , 2017, Cell reports.
[54] L. Fiette,et al. Injury-Induced Senescence Enables In Vivo Reprogramming in Skeletal Muscle. , 2017, Cell stem cell.
[55] Dylan M. Marchione,et al. Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas , 2017, Nature Genetics.
[56] C. R. Esteban,et al. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming , 2016, Cell.
[57] D. Mager,et al. Endogenous retroviral promoter exaptation in human cancer , 2016, Mobile DNA.
[58] M. Blasco,et al. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo , 2016, Science.
[59] C. Feschotte,et al. Regulatory activities of transposable elements: from conflicts to benefits , 2016, Nature Reviews Genetics.
[60] I. Petersen,et al. Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking , 2016, Nature Genetics.
[61] J. García-Pérez,et al. The impact of transposable elements on mammalian development , 2016, Development.
[62] B. Bonev,et al. Organization and function of the 3D genome , 2016, Nature Reviews Genetics.
[63] B. Tian,et al. Alternative polyadenylation of mRNA precursors , 2016, Nature Reviews Molecular Cell Biology.
[64] M. Boutros,et al. Wnt signaling in cancer , 2016, Oncogene.
[65] Jianlong Wang,et al. Zfp281 Coordinates Opposing Functions of Tet1 and Tet2 in Pluripotent States. , 2016, Cell stem cell.
[66] Salvador Aznar Benitah,et al. Epigenetic control of adult stem cell function , 2016, Nature Reviews Molecular Cell Biology.
[67] Wouter de Laat,et al. The second decade of 3C technologies: detailed insights into nuclear organization , 2016, Genes & development.
[68] Howard Cedar,et al. DNA Methylation in Cancer and Aging. , 2016, Cancer research.
[69] Lei S. Qi,et al. CRISPR/Cas9 in Genome Editing and Beyond. , 2016, Annual review of biochemistry.
[70] S. Thibodeau,et al. The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas , 2016, Science.
[71] B. Garcia,et al. Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape , 2016, Science.
[72] Thomas G. Gilgenast,et al. Local Genome Topology Can Exhibit an Incompletely Rewired 3D-Folding State during Somatic Cell Reprogramming. , 2016, Cell stem cell.
[73] Peter H. L. Krijger,et al. Cell-of-Origin-Specific 3D Genome Structure Acquired during Somatic Cell Reprogramming , 2016, Cell stem cell.
[74] B. Cieply,et al. Multiphasic and Dynamic Changes in Alternative Splicing during Induction of Pluripotency Are Coordinated by Numerous RNA-Binding Proteins. , 2016, Cell reports.
[75] T. Pandita,et al. The many faces of histone H3K79 methylation. , 2016, Mutation research. Reviews in mutation research.
[76] K. Helin,et al. Role of TET enzymes in DNA methylation, development, and cancer , 2016, Genes & development.
[77] Brian D. Bennett,et al. A Serial shRNA Screen for Roadblocks to Reprogramming Identifies the Protein Modifier SUMO2 , 2016, Stem cell reports.
[78] Greg G. Wang,et al. Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming. , 2016, Cell stem cell.
[79] Alexander van Oudenaarden,et al. Replacement of Lost Lgr5-Positive Stem Cells through Plasticity of Their Enterocyte-Lineage Daughters. , 2016, Cell stem cell.
[80] P. Ordóñez-Morán,et al. Polycomb Complex PRC1 Preserves Intestinal Stem Cell Identity by Sustaining Wnt/β-Catenin Transcriptional Activity. , 2016, Cell stem cell.
[81] Shawn M. Gillespie,et al. Insulator dysfunction and oncogene activation in IDH mutant gliomas , 2015, Nature.
[82] Howard Y. Chang,et al. The histone chaperone CAF-1 safeguards somatic cell identity , 2015, Nature.
[83] Dong Ryul Lee,et al. Histone Demethylase Expression Enhances Human Somatic Cell Nuclear Transfer Efficiency and Promotes Derivation of Pluripotent Stem Cells. , 2015, Cell stem cell.
[84] Rong Wang,et al. Coordination of m(6)A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming. , 2015, Cell stem cell.
[85] Daniel S. Day,et al. Activation of proto-oncogenes by disruption of chromosome neighborhoods , 2015, Science.
[86] George Q. Daley,et al. Systematic Identification of Factors for Provirus Silencing in Embryonic Stem Cells , 2015, Cell.
[87] Wei Li,et al. NUDT21-spanning CNVs lead to neuropsychiatric disease and altered MeCP2 abundance via alternative polyadenylation , 2015, eLife.
[88] Juan M. Vaquerizas,et al. Early embryonic-like cells are induced by downregulating replication-dependent chromatin assembly , 2015, Nature Structural &Molecular Biology.
[89] Chuan He,et al. RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation , 2015, Genes & development.
[90] A. Visel,et al. Disruptions of Topological Chromatin Domains Cause Pathogenic Rewiring of Gene-Enhancer Interactions , 2015, Cell.
[91] Qi Zhou,et al. m(6)A RNA methylation is regulated by microRNAs and promotes reprogramming to pluripotency. , 2015, Cell stem cell.
[92] D. Fan,et al. The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links. , 2015, Current pharmaceutical design.
[93] Erez Y. Levanon,et al. m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation , 2015, Science.
[94] Jing Liang,et al. Chromatin architecture reorganization during stem cell differentiation , 2015, Nature.
[95] C. Allis,et al. Use of human embryonic stem cells to model pediatric gliomas with H3.3K27M histone mutation , 2014, Science.
[96] Yi Xing,et al. m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. , 2014, Cell stem cell.
[97] M. Zenke,et al. Pcgf6, a Polycomb Group Protein, Regulates Mesodermal Lineage Differentiation in Murine ESCs and Functions in iPS Reprogramming , 2014, Stem cells.
[98] Shogo Matoba,et al. Embryonic Development following Somatic Cell Nuclear Transfer Impeded by Persisting Histone Methylation , 2014, Cell.
[99] L. Hurst,et al. Primate-specific endogenous retrovirus-driven transcription defines naive-like stem cells , 2014, Nature.
[100] A. Tsirigos,et al. Combinatorial Modulation of Signaling Pathways Reveals Cell-Type-Specific Requirements for Highly Efficient and Synchronous iPSC Reprogramming , 2014, Stem cell reports.
[101] S. Ramaswamy,et al. Small molecules facilitate rapid and synchronous iPSC generation , 2014, Nature Methods.
[102] H. Otu,et al. Histone chaperone ASF1A is required for maintenance of pluripotency and cellular reprogramming , 2014, Science.
[103] W. Paschen,et al. SUMO2 is essential while SUMO3 is dispensable for mouse embryonic development , 2014, EMBO reports.
[104] Jignesh R. Parikh,et al. Alternative splicing of MBD2 supports self-renewal in human pluripotent stem cells. , 2014, Cell stem cell.
[105] A. Radzisheuskaya,et al. MBD3/NuRD Facilitates Induction of Pluripotency in a Context-Dependent Manner , 2014, Cell stem cell.
[106] Wolfgang Huber,et al. Enhancer loops appear stable during development and are associated with paused polymerase , 2014, Nature.
[107] B. Ren,et al. The 3D genome in transcriptional regulation and pluripotency. , 2014, Cell stem cell.
[108] Gad Getz,et al. Somatic retrotransposition in human cancer revealed by whole-genome and exome sequencing , 2014, Genome research.
[109] Wei Li,et al. CFIm25 links Alternative Polyadenylation to Glioblastoma Tumor Suppression , 2014, Nature.
[110] Martin S. Taylor,et al. Long interspersed element-1 protein expression is a hallmark of many human cancers. , 2014, The American journal of pathology.
[111] S. Baylin,et al. The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes , 2014, Oncogene.
[112] Xiaohui S. Xie,et al. Fip1 regulates mRNA alternative polyadenylation to promote stem cell self‐renewal , 2014, The EMBO journal.
[113] Britta A. M. Bouwman,et al. A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia , 2014, Cell.
[114] W. Liu,et al. Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming. , 2014, Cell stem cell.
[115] S. Yamanaka,et al. Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation , 2014, Cell.
[116] S. Orkin,et al. Polycomb repressive complex 2 regulates normal hematopoietic stem cell function in a developmental-stage-specific manner. , 2014, Cell stem cell.
[117] Denis Thieffry,et al. C/EBPα poises B cells for rapid reprogramming into induced pluripotent stem cells , 2013, Nature.
[118] Matteo Pellegrini,et al. Long-range chromatin contacts in embryonic stem cells reveal a role for pluripotency factors and polycomb proteins in genome organization. , 2013, Cell stem cell.
[119] Benjamin D. Medoff,et al. Dedifferentiation of committed epithelial cells into stem cells in vivo , 2013, Nature.
[120] S. Yamanaka,et al. Global splicing pattern reversion during somatic cell reprogramming. , 2013, Cell reports.
[121] K. Hochedlinger,et al. Chromatin dynamics during cellular reprogramming , 2013, Nature.
[122] Zohar Mukamel,et al. Deterministic direct reprogramming of somatic cells to pluripotency , 2013, Nature.
[123] M. Serrano,et al. Reprogramming in vivo produces teratomas and iPS cells with totipotency features , 2013, Nature.
[124] I. Grummt,et al. NuRD Blocks Reprogramming of Mouse Somatic Cells into Pluripotent Stem Cells , 2013, Stem cells.
[125] Bruno Di Stefano,et al. Polycomb complexes in stem cells and embryonic development , 2013, Development.
[126] B. Garcia,et al. Proteomic and genomic approaches reveal critical functions of H3K9 methylation and Heterochromatin Protein-1γ in reprogramming to pluripotency , 2013, Nature Cell Biology.
[127] Jennifer E. Phillips-Cremins,et al. Architectural Protein Subclasses Shape 3D Organization of Genomes during Lineage Commitment , 2013, Cell.
[128] Francesco Ferrari,et al. Genome-wide chromatin interactions of the Nanog locus in pluripotency, differentiation, and reprogramming. , 2013, Cell stem cell.
[129] Eric T. Wang,et al. MBNL proteins repress ES-cell-specific alternative splicing and reprogramming , 2013, Nature.
[130] B. Garcia,et al. Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma , 2013, Science.
[131] D. Koh,et al. The proto-oncoprotein FBI-1 interacts with MBD3 to recruit the Mi-2/NuRD-HDAC complex and BCoR and to silence p21WAF/CDKN1A by DNA methylation , 2013, Nucleic acids research.
[132] G. Viglietto,et al. Nonredundant and locus-specific gene repression functions of PRC1 paralog family members in human hematopoietic stem/progenitor cells. , 2013, Blood.
[133] Samir Karaca,et al. Detecting endogenous SUMO targets in mammalian cells and tissues , 2013, Nature Structural &Molecular Biology.
[134] K. Helin,et al. Polycomb Cbx family members mediate the balance between haematopoietic stem cell self-renewal and differentiation , 2013, Nature Cell Biology.
[135] B. Garcia,et al. MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency , 2013, Nature Communications.
[136] R. Russell,et al. Intestinal label-retaining cells are secretory precursors expressing Lgr5 , 2013, Nature.
[137] Zachary D. Smith,et al. DNA methylation: roles in mammalian development , 2013, Nature Reviews Genetics.
[138] G. Pruneri,et al. Cell Reprogramming Requires Silencing of a Core Subset of Polycomb Targets , 2013, PLoS genetics.
[139] W. Reik,et al. Nanog-dependent function of Tet1 and Tet2 in establishment of pluripotency , 2013, Nature.
[140] P. Arlotta,et al. Direct lineage reprogramming of post-mitotic callosal neurons into corticofugal neurons in vivo , 2013, Nature Cell Biology.
[141] Jieying Zhu,et al. H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs , 2012, Nature Genetics.
[142] Yongsheng Shi,et al. Alternative polyadenylation: new insights from global analyses. , 2012, RNA.
[143] Greg Donahue,et al. Facilitators and Impediments of the Pluripotency Reprogramming Factors' Initial Engagement with the Genome , 2012, Cell.
[144] S. González,et al. Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest. , 2012, Cell stem cell.
[145] E. Ballestar,et al. Tet2 facilitates the derepression of myeloid target genes during CEBPα-induced transdifferentiation of pre-B cells. , 2012, Molecular cell.
[146] Thomas Vierbuchen,et al. Molecular roadblocks for cellular reprogramming. , 2012, Molecular cell.
[147] A. Oudenaarden,et al. Dll1+ secretory progenitor cells revert to stem cells upon crypt damage , 2012, Nature Cell Biology.
[148] Sandy L. Klemm,et al. Single-Cell Expression Analyses during Cellular Reprogramming Reveal an Early Stochastic and a Late Hierarchic Phase , 2012, Cell.
[149] G. Bhagat,et al. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2 , 2012, Nature.
[150] Muneef Ayyash,et al. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming , 2012, Nature.
[151] Shawn P. Driscoll,et al. ES cell potency fluctuates with endogenous retrovirus activity , 2012, Nature.
[152] Xiaoxia Qi,et al. Heart repair by reprogramming non-myocytes with cardiac transcription factors , 2012, Nature.
[153] J. Sedat,et al. Spatial partitioning of the regulatory landscape of the X-inactivation centre , 2012, Nature.
[154] Jesse R. Dixon,et al. Topological Domains in Mammalian Genomes Identified by Analysis of Chromatin Interactions , 2012, Nature.
[155] M. Surani,et al. Epiblast Stem Cell-Based System Reveals Reprogramming Synergy of Germline Factors , 2012, Cell stem cell.
[156] Paul Polakis,et al. Wnt signaling in cancer. , 2012, Cold Spring Harbor perspectives in biology.
[157] Tom H. Cheung,et al. Alternative polyadenylation mediates microRNA regulation of muscle stem cell function. , 2012, Cell stem cell.
[158] Eric S. Lander,et al. Chromatin modifying enzymes as modulators of reprogramming , 2012, Nature.
[159] A. Iwama,et al. Dependency on the polycomb gene Ezh2 distinguishes fetal from adult hematopoietic stem cells. , 2011, Blood.
[160] G. Pan,et al. The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. , 2011, Cell stem cell.
[161] Andrew P. Feinberg,et al. Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells , 2011, Nature Biotechnology.
[162] Li Qian,et al. In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes , 2011, Nature.
[163] Jeffrey L. Wrana,et al. An Alternative Splicing Switch Regulates Embryonic Stem Cell Pluripotency and Reprogramming , 2011, Cell.
[164] R. Young,et al. Genome-wide maps of histone modifications unwind in vivo chromatin states of the hair follicle lineage. , 2011, Cell stem cell.
[165] R. Shiekhattar,et al. Jarid2 regulates mouse epidermal stem cell activation and differentiation , 2011, The EMBO journal.
[166] Lars Bullinger,et al. MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. , 2011, Cancer cell.
[167] P. Wade,et al. Cancer biology and NuRD: a multifaceted chromatin remodelling complex , 2011, Nature Reviews Cancer.
[168] Emily Bernstein,et al. Stem cells and reprogramming: breaking the epigenetic barrier? , 2011, Trends in pharmacological sciences.
[169] A. Gillich,et al. Histone variant macroH2A confers resistance to nuclear reprogramming , 2011, The EMBO journal.
[170] Jonathan M. Monk,et al. Wdr5 Mediates Self-Renewal and Reprogramming via the Embryonic Stem Cell Core Transcriptional Network , 2011, Cell.
[171] Paul Tempst,et al. PRC2 Complexes with JARID2, MTF2, and esPRC2p48 in ES Cells to Modulate ES Cell Pluripotency and Somatic Cell Reprograming , 2011, Stem cells.
[172] Oliver Hobert,et al. Direct Conversion of C. elegans Germ Cells into Specific Neuron Types , 2011, Science.
[173] A. Behrens,et al. c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex , 2011, Nature.
[174] G. Mizuguchi,et al. Stepwise Histone Replacement by SWR1 Requires Dual Activation with Histone H2A.Z and Canonical Nucleosome , 2010, Cell.
[175] Krishanu Saha,et al. Pluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues , 2010, Cell.
[176] B. Garcia,et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8 , 2010, Nature.
[177] K. Hochedlinger,et al. Induced pluripotency: history, mechanisms, and applications. , 2010, Genes & development.
[178] V. Vedantham,et al. Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors , 2010, Cell.
[179] K. Hochedlinger,et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells , 2010, Nature Biotechnology.
[180] Martin J. Aryee,et al. Epigenetic memory in induced pluripotent stem cells , 2010, Nature.
[181] H. Blau,et al. Nuclear reprogramming to a pluripotent state by three approaches , 2010, Nature.
[182] T. Pawson,et al. Post-translational modifications in signal integration , 2010, Nature Structural &Molecular Biology.
[183] Alexander R. Pico,et al. Alternative splicing regulates mouse embryonic stem cell pluripotency and differentiation , 2010, Proceedings of the National Academy of Sciences.
[184] Ralph Stadhouders,et al. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma , 2010, Nature Medicine.
[185] A. Iwama,et al. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. , 2010, Cell stem cell.
[186] Z. Nagy,et al. Rapid elimination of the histone variant MacroH2A from somatic cell heterochromatin after nuclear transfer. , 2010, Cellular reprogramming.
[187] H. Redl,et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. , 2010, Cell stem cell.
[188] T. Hothorn,et al. Histone macroH2A isoforms predict the risk of lung cancer recurrence , 2009, Oncogene.
[189] Gene W. Yeo,et al. L1 retrotransposition in human neural progenitor cells , 2009, Nature.
[190] T. Ichisaka,et al. Suppression of induced pluripotent stem cell generation by the p53–p21 pathway , 2009, Nature.
[191] Manuel Serrano,et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity , 2009, Nature.
[192] M. Blasco,et al. The Ink4/Arf locus is a barrier for iPS cell reprogramming , 2009, Nature.
[193] J. Utikal,et al. Immortalization eliminates a roadblock during cellular reprogramming into iPS cells , 2009, Nature.
[194] G. Wahl,et al. Linking the p53 tumor suppressor pathway to somatic cell reprogramming , 2009, Nature.
[195] Suchit Jhunjhunwala,et al. Chromatin Architecture and the Generation of Antigen Receptor Diversity , 2009, Cell.
[196] C. Mayr,et al. Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.
[197] J. Nichols,et al. Naive and primed pluripotent states. , 2009, Cell stem cell.
[198] David R. Liu,et al. Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .
[199] J. Nichols,et al. Klf4 reverts developmentally programmed restriction of ground state pluripotency , 2009, Development.
[200] G. Hannon,et al. Ezh2 Orchestrates Gene Expression for the Stepwise Differentiation of Tissue-Specific Stem Cells , 2009, Cell.
[201] K. Hochedlinger,et al. Epigenetic reprogramming and induced pluripotency , 2009, Development.
[202] D. Melton,et al. Nuclear Reprogramming in Cells , 2008, Science.
[203] H. Cedar,et al. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes , 2008, Nature Structural &Molecular Biology.
[204] T. Mikkelsen,et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.
[205] Eric S. Lander,et al. Dissecting direct reprogramming through integrative genomic analysis , 2008, Nature.
[206] P. Sharp,et al. Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites , 2008, Science.
[207] R. Jaenisch,et al. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice , 2008, Oncogene.
[208] Shulan Tian,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[209] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[210] T. Graf. Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors. , 2007 .
[211] E. Li,et al. Synergistic Function of DNA Methyltransferases Dnmt3a and Dnmt3b in the Methylation of Oct4 and Nanog , 2007, Molecular and Cellular Biology.
[212] M. Trotter,et al. Derivation of pluripotent epiblast stem cells from mammalian embryos , 2007, Nature.
[213] R. McKay,et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells , 2007, Nature.
[214] S. Yamanaka. Strategies and new developments in the generation of patient-specific pluripotent stem cells. , 2007, Cell stem cell.
[215] W. Reik. Stability and flexibility of epigenetic gene regulation in mammalian development , 2007, Nature.
[216] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[217] R. Jaenisch,et al. Reprogramming Efficiency Following Somatic Cell Nuclear Transfer Is Influenced by the Differentiation and Methylation State of the Donor Nucleus , 2006, Stem cells.
[218] S. Yamanaka,et al. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.
[219] Andrew P Feinberg,et al. The epigenetics of cancer etiology. , 2004, Seminars in cancer biology.
[220] T. Chevassut,et al. Severe Global DNA Hypomethylation Blocks Differentiation and Induces Histone Hyperacetylation in Embryonic Stem Cells , 2004, Molecular and Cellular Biology.
[221] H. Lauke,et al. Cell Type-specific Expression of LINE-1 Open Reading Frames 1 and 2 in Fetal and Adult Human Tissues* , 2004, Journal of Biological Chemistry.
[222] S. Ramaswamy,et al. Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.
[223] S. Morrison,et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation , 2003, Nature.
[224] E. Li,et al. Establishment and Maintenance of Genomic Methylation Patterns in Mouse Embryonic Stem Cells by Dnmt3a and Dnmt3b , 2003, Molecular and Cellular Biology.
[225] G. Sauvageau,et al. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells , 2003, Nature.
[226] Irving L. Weissman,et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells , 2003, Nature.
[227] Karl Mechtler,et al. Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability , 2001, Cell.
[228] A. Wolffe,et al. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[229] B. Stillman,et al. Heterochromatin dynamics in mouse cells: interaction between chromatin assembly factor 1 and HP1 proteins. , 1999, Molecular cell.
[230] I. Wilmut,et al. Sheep cloned by nuclear transfer from a cultured cell line , 1996, Nature.
[231] M. Sofroniew,et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. , 1994, Genes & development.
[232] P. Donovan,et al. Long-term proliferation of mouse primordial germ cells in culture , 1992, Nature.
[233] B. Hogan,et al. Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture , 1992, Cell.
[234] K. Kinzler,et al. Disruption of the APC gene by a retrotransposal insertion of L1 sequence in a colon cancer. , 1992, Cancer research.
[235] B. Stillman,et al. Purification and characterization of CAF-I, a human cell factor required for chromatin assembly during DNA replication in vitro , 1989, Cell.
[236] J. Spandorfer,et al. Insertional mutagenesis of the myc locus by a LINE-1 sequence in a human breast carcinoma , 1988, Nature.
[237] H. Weintraub,et al. Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.
[238] G. Martin,et al. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[239] M. Kaufman,et al. Establishment in culture of pluripotential cells from mouse embryos , 1981, Nature.
[240] T. Elsdale,et al. Sexually Mature Individuals of Xenopus laevis from the Transplantation of Single Somatic Nuclei , 1958, Nature.
[241] C. Collins,et al. SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition. , 2017, European urology.
[242] C. Pilarsky,et al. The EMT-activator Zeb 1 is a key factor for cell plasticity and promotes metastasis in 1 pancreatic cancer 2 , 2017 .
[243] K. Zaret,et al. H3K9me3-Dependent Heterochromatin: Barrier to Cell Fate Changes. , 2016, Trends in genetics : TIG.
[244] M. Rauchman,et al. The nucleosome remodeling and deacetylase complex in development and disease. , 2015, Translational research : the journal of laboratory and clinical medicine.
[245] M. Esteller,et al. DNA methylation and cancer. , 2010, Advances in genetics.
[246] L. Allen. Stem cells. , 2003, The New England journal of medicine.